Arcadia Biosciences, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 5.33 million compared to USD 7.42 million a year ago. Net loss was USD 13.98 million compared to USD 15.38 million a year ago.

Basic loss per share from continuing operations was USD 10.64 compared to USD 17.67 a year ago.